MedMira Inc faces a significant downturn as its stock price drops sharply.
MedMira Inc (MIR.V) is experiencing a notable decline in its stock price today, with shares falling by 7.69% to close at CA$0.06. This drop raises concerns among investors about the company's market performance and future prospects.
Investor takeaway: Investors should closely monitor MedMira's developments and market conditions, as the recent stock decline highlights potential vulnerabilities.
Advertisement
Earn cash back with a smarter spending account
Open a KOHO account and start earning on everyday purchases — no annual fee on the base plan.
MedMira Inc
MIR.V
MIR.V
MedMira Inc
WealthAwesomeMarket cap
$43.86M
52W high
$0.11
52W low
$0.05
1W change
+0.00%
Beta
0.79
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MIR's historical volatility
30-Day Vol
98.8%
Annualized
90-Day Vol
105.3%
Annualized
Trend (90d)
+33.6%
Annualized drift
90d Mean
C$0.07
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.07 | C$0.05 – C$0.10 |
| 60 trading days | C$0.07 | C$0.04 – C$0.11 |
| 90 trading days | C$0.07 | C$0.04 – C$0.13 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
MedMira Inc stock down 7.69% today
The stock's decline today reflects broader concerns about MedMira's market performance amidst recent developments.
Bull case
Even with the current downturn, MedMira has made progress by securing Health Canada approvals for its rapid tests. This could open doors for future growth opportunities.
Bear case
The significant drop in stock price today may signal underlying issues within the company or negative market sentiment, which could deter potential investors.
Current Stock Performance
Advertisement
MedMira Inc's stock is down 7.69% today, closing at CA$0.06. This decline raises questions about the company's stability and investor confidence as it faces a challenging market environment.
Recent Developments
While MedMira has been in the news for securing Health Canada approvals for its rapid tests, today's stock performance suggests that investors may be reacting to broader market conditions or internal challenges. For more insights on MedMira's recent achievements, check out our coverage on MedMira's Health Canada approval and clinical trials.
Market Sentiment
The market's reaction to MedMira's stock today may reflect broader investor sentiment towards small-cap healthcare companies. As MedMira navigates its growth strategy, the current stock decline underscores the importance of monitoring both company-specific news and overall market trends. For a deeper dive into MedMira's financials, visit our page on MIR.V.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
